<b> Two investigative journalists have raised the question whether the new blood pressure drug, Transerythropaxil, has sensitized patients to develop fish allergies  </b> The study was published last month in a major newspaper, and has been picked up by media throughout the country  <b> Lab data has long shown that Transerythropaxil reacts strongly with Eicosapentaenoic acid, found in abundance in fish oil, and this reaction can produce biological irritants
</b> Despite strenuous objections from Transerythropaxil' s manufacturer, scientists working in federal labs have just published papers that provide conclusive evidence to the journalists' claim
The first provides support for conclusion of the argument; the second calls that conclusion into question.